Blackhawk Growth Files Fiscal Year Ended June 30, 2021 Financial Reports

Blackhawk Growth Files Fiscal Year Ended June 30, 2021 Financial Reports

Vancouver, British Columbia – TheNewswire – October 29, 2021 – Blackhawk Growth Corp. (CSNX:BLR.CN) (OTC:BLRZF) (Frankfurt:0JJ) (the “Company”), is pleased to announce that the financial statements and MD&A for its fiscal year ended June 30, 2021 have been filed on Sedar.

Highlights for the fiscal year ended June 30, 2021:

  • – Blackhawk portfolio companies have recorded annual gross revenue of over $3,900,000

    – Portfolio Company Annual Operations Results:

    • – Noble Hemp reports record $1,700,000 of gross revenue

      – Sac Pharma reports record $2,100,000 of gross revenue

    – Spaced Food begins production of cannabis infused products for retail distribution

    – LeichtMind Clinic opens in Edmonton

    – As at June 30, 2021, Blackhawk held $6,318,835 in current investments.


Blackhawk Growth Corp. (“Blackhawk” or the “Company”) continues to review both equity and debt investment opportunities. The Company has focused its investments in the health, cannabis and CBD industries, in both Canada and the US.


As at June 30, 2021 the Company’s equity investments consist of the following:

Company Cost Fair Value
SAC Pharma Partners Inc. $        1,890,000 $        1,890,000
Noble Line Inc.         951,195         901,145
Trip Pharma 923,344 923,344
NuWave Foods Inc. 783,892 783,892
Gaia Grow Corp. 1,050,000 1,500,000
Engine Media (UMG) 41,043 56,377
Fantasy Aces Daily Fantasy Sports Corp. 455,268 9,470
Spaced Food Inc. 254,607 254,607
Total Equity Investments $6,349,349 $        6,318,835

Short-term loans consist of the following:

June 30, 2021 June 30, 2020
Short term loans 259,609 349,609
Total loan investments $        259,609 $        349,609


About Blackhawk Growth


Blackhawk is an investment holding company looking to create substantial value for its shareholders through the acquisition and development of high growth companies. It has focused its investments in the health, cannabis and cannabidiol industries in both Canada and the United States. Its portfolio of companies includes Sac Pharma, LeichtMind Clinics, Noble Hemp, Spaced Food, NuWave Foods, and MindBio Therapeutics. Blackhawk continues to bring its investments to cash flow and is growing at an exceeding pace.

The company diligently posts updates through videos from the official company YouTube channel


Please join the conversation on our Blackhawk group supporter’s telegram group at and visit us online at


For more information on Blackhawk, please visit our website at:

Frederick Pels, Chief Executive Officer


Cautionary Note Regarding Forward-Looking Statement


All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to the future prospects of the business of the Company and its portfolio companies. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.